−60 KRW
−164.04 M KRW
52.81 B KRW
65.25 M
About HLBBIOSTEP
Sector
CEO
Jung-Hwan Moon
Headquarters
Inchon
Founded
2012
ISIN
KR7278650007
FIGI
BBG00QKHL3L9
HLB bioStep Co., Ltd. engages in the provision of clinical research services. It operates through the following business divisions: Non-Clinical Contract Research Organizations (CRO), Bioinfrastructure, and Pet Medical. The Non-Clinical CRO business division focuses on pharmacology and toxicity evaluation. The Bioinfrastructure business division is invloved in the design, construction, and maintenance of animal testing facilities, as well as supply of equipment and materials. The Pet Medical business division distributes and sells veterinary medicines. The company was founded on April 19, 2012 and is headquartered in Inchon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 278650 is 2,095 KRW — it has increased by 4.75% in the past 24 hours. Watch HLBBIOSTEP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HLBBIOSTEP stocks are traded under the ticker 278650.
278650 stock has risen by 4.75% compared to the previous week, the month change is a −2.10% fall, over the last year HLBBIOSTEP has showed a −33.49% decrease.
278650 reached its all-time high on Jun 13, 2022 with the price of 43,950 KRW, and its all-time low was 1,120 KRW and was reached on Mar 17, 2020. View more price dynamics on 278650 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
278650 stock is 5.26% volatile and has beta coefficient of 1.08. Track HLBBIOSTEP stock price on the chart and check out the list of the most volatile stocks — is HLBBIOSTEP there?
Today HLBBIOSTEP has the market capitalization of 176.39 B, it has decreased by −5.47% over the last week.
Yes, you can track HLBBIOSTEP financials in yearly and quarterly reports right on TradingView.
278650 net income for the last quarter is −498.08 M KRW, while the quarter before that showed −3.09 B KRW of net income which accounts for 83.90% change. Track more HLBBIOSTEP financial stats to get the full picture.
As of Dec 31, 2024, the company has 174.00 employees. See our rating of the largest employees — is HLBBIOSTEP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLBBIOSTEP EBITDA is −4.31 B KRW, and current EBITDA margin is 4.34%. See more stats in HLBBIOSTEP financial statements.
Like other stocks, 278650 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLBBIOSTEP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLBBIOSTEP technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLBBIOSTEP stock shows the sell signal. See more of HLBBIOSTEP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.